Home › NDC Lookup › RxCUI directory › RxCUI 2712691

Sapropterin dihydrochloride 500 MG Powder for Oral Solution [Zelvysia] — RxCUI 2712691

RxNorm drug concept · Semantic branded drug
RxCUI 2712691 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2712691
Official nameSapropterin dihydrochloride 500 MG Powder for Oral Solution [Zelvysia]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asZelvysia 500 MG Powder for Oral Solution
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sapropterin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Sapropterin gives your body more of a helper molecule called BH4 that the enzyme responsible for breaking down phenylalanine needs to work. If you have BH4-responsive PKU, this can...
  • What exactly does sapropterin do, and why do I still have to follow a special diet?
  • Your doctor will check your blood phenylalanine levels regularly after you start the medication. If the drug is working, your levels should start to drop within the first 24 hours,...
  • How will I know if sapropterin is actually working for me?
📖 Read our full Sapropterin guide →

🕸️ Concept Web — How Sapropterin dihydrochloride 500 MG Powder for Or... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Sapropterin dihydrochloride 500 MG Powder for Oral Solution [Zelvysia] RxCUI 2712691

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Sapropterin 753340
    • Sapropterin dihydrochloride 753341
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Zelvysia 2712683
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sapropterin Powder for Oral Solution 1653216
    • Sapropterin dihydrochloride Powder for Oral Solution 2647252
    • Sapropterin Oral Powder Product 1653215
    • Sapropterin Oral Product 1157609
    • Sapropterin dihydrochloride Oral Powder Product 2662866
    • Sapropterin dihydrochloride Oral Product 2662130
    • Sapropterin Powder for Oral Solution [Zelvysia] 2712687
    • Sapropterin dihydrochloride Powder for Oral Solution [Zelvysia] 2712688
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sapropterin dihydrochloride 500 MG Powder for Oral Solution SCD · 1653217
  • Sapropterin dihydrochloride 500 MG SCDC · 1653214
  • Sapropterin Powder for Oral Solution SCDF · 1653216
  • Sapropterin dihydrochloride Powder for Oral Solution SCDFP · 2647252
  • Sapropterin Oral Powder Product SCDG · 1653215
  • Sapropterin Oral Product SCDG · 1157609
  • Sapropterin dihydrochloride Oral Powder Product SCDGP · 2662866
  • Sapropterin dihydrochloride Oral Product SCDGP · 2662130

Brand-Name Concepts

  • Sapropterin dihydrochloride 500 MG [Zelvysia] SBDC · 2712690
  • Sapropterin Powder for Oral Solution [Zelvysia] SBDF · 2712687
  • Sapropterin dihydrochloride Powder for Oral Solution [Zelvysia] SBDFP · 2712688
  • Zelvysia Oral Powder Product SBDG · 2712686
  • Zelvysia Oral Product SBDG · 2712685
  • Zelvysia BN · 2712683

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 2712691 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
73289-0070-02 30 PACKET in 1 CARTON (73289-0070-2) / 1 POWDER, FOR SOLUTI... ZELVYSIA Aucta Pharmaceuticals, Inc. 2025-04-29
73289-0071-02 30 PACKET in 1 CARTON (73289-0071-2) / 1 POWDER, FOR SOLUTI... ZELVYSIA Aucta Pharmaceuticals, Inc. 2025-04-29
Observed labelers: Aucta Pharmaceuticals, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.